Perfect Medical Health Management Limited (1830) AI Stock Analysis

• Market Cap: HK$2.06B
• Dividend Yield: 17.44%
• Average Volume (3M): 1.34M
• Price to Earnings (P/E): 10.0
• Beta (1Y): 0.87
• Revenue Growth: -19.05%
• EPS Growth: -34.49%
• Country: HK
• Employees: 1,161
• Sector: Consumer Cyclical
• Sector Strength: 73
• Industry: Personal Products & Services
• EPS (TTM): 0.05
• Shares Outstanding: 1,256,197,800
• 10 Day Avg. Volume: 847,891
• 30 Day Avg. Volume: 1,343,118
• PEG Ratio: -0.38
• Price to Book (P/B): 7.51
• Price to Sales (P/S): 2.53
• P/FCF Ratio: 9.56
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: HK$1.50
• Price Target Upside: -8.54% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 62 Neutral
• Price Target: HK$1.50 ▼(-8.54% Downside)

The overall stock score is driven by strong valuation metrics, with a low P/E ratio and high dividend yield, making it attractive for value investors. However, the score is tempered by bearish technical indicators and challenges in revenue and cash flow growth, which suggest caution. The company's strong profitability and stable balance sheet provide some support, but the lack of positive momentum and growth prospects weigh on the overall assessment.

Perfect Medical Health Management Limited Business Overview & Revenue Model

Company Description

Perfect Medical Health Management Limited (1830) is a healthcare management company that specializes in providing comprehensive health management solutions, including telemedicine services, health data analytics, and personalized patient care programs. Operating primarily in the healthcare sector, the company focuses on enhancing patient outcomes through technology-driven solutions and integrated healthcare services.

How the Company Makes Money

The company generates revenue through multiple streams, including subscription fees from healthcare providers for access to its telemedicine platform, consulting fees for health data analytics services, and fees from personalized health program implementations. In addition, Perfect Medical Health Management Limited has established strategic partnerships with hospitals and insurance companies, allowing it to offer bundled services and gain a share of the revenue from the healthcare transactions facilitated through its platform. These partnerships enhance its credibility and expand its customer base, contributing significantly to its earnings.

Perfect Medical Health Management Limited Financial Statement Overview

Summary

The company demonstrates strong profitability with healthy profit margins and a stable balance sheet. However, it faces challenges in revenue and free cash flow growth, which highlights potential areas for improvement in sustaining growth momentum.

Income Statement

The company has experienced a decline in revenue growth, with a notable decrease of 12.94% in the latest year. However, it maintains healthy profitability margins, with a gross profit margin of 63.77% and a net profit margin of 18.34%. The EBIT and EBITDA margins are also strong at 23.37% and 39.19%, respectively. Despite the revenue decline, the company demonstrates solid profitability.

Balance Sheet

The balance sheet shows a moderate debt-to-equity ratio of 0.57, indicating a balanced leverage position. The return on equity is robust at 54.45%, reflecting efficient use of equity to generate profits. The equity ratio stands at 40.59%, suggesting a stable financial structure with adequate equity backing.

Cash Flow

The company has faced a decline in free cash flow growth, down by 16.77% in the latest year. However, the operating cash flow to net income ratio is strong at 0.83, and the free cash flow to net income ratio is 0.90, indicating effective cash generation relative to net income. Despite the decline in free cash flow growth, the company maintains a solid cash flow position.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	1.30B	1.13B	1.39B	1.39B	1.35B	1.09B
Gross Profit	819.54M	719.22M	911.37M	662.60M	689.93M	553.44M
EBITDA	405.50M	441.97M	596.91M	592.40M	602.84M	474.13M
Net Income	290.25M	206.90M	315.80M	315.64M	305.25M	284.63M
Balance Sheet
Total Assets	1.08B	935.91M	1.22B	1.30B	1.28B	1.48B
Cash, Cash Equivalents and Short-Term Investments	471.42M	386.80M	567.40M	656.85M	454.37M	532.89M
Total Debt	238.70M	216.65M	268.73M	240.35M	311.07M	261.60M
Total Liabilities	634.89M	557.18M	725.00M	684.02M	786.93M	795.52M
Stockholders Equity	452.19M	379.95M	497.51M	612.27M	494.27M	684.85M
Cash Flow
Free Cash Flow	358.30M	298.23M	445.50M	533.81M	372.16M	527.69M
Operating Cash Flow	412.48M	332.88M	497.12M	560.55M	516.71M	605.91M
Investing Cash Flow	-235.97M	-171.93M	162.56M	-222.51M	8.05M	-300.82M
Financing Cash Flow	-517.69M	-477.95M	-520.97M	-335.02M	-565.97M	-394.41M

Perfect Medical Health Management Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1.64
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1830, the sentiment is Negative. The current price of 1.64 is below the 20-day moving average (MA) of 1.67, below the 50-day MA of 1.86, and below the 200-day MA of 2.17, indicating a bearish trend. The MACD of -0.06 indicates Negative momentum. The RSI at 37.93 is Neutral, neither overbought nor oversold. The STOCH value of 39.65 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1830.

Perfect Medical Health Management Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
8603	72 Outperform	HK$1.16B	25.35	54.98%	―	45.40%	12.38%
1161	69 Neutral	$598.89M	7.14	25.63%	6.25%	-1.62%	-10.07%
1830	62 Neutral	HK$2.06B	9.96	47.16%	17.44%	-19.05%	-34.49%
Sector *	61 Neutral	$16.98B	10.44	-7.45%	3.24%	1.51%	-15.34%
0919	56 Neutral	€89.54M	24.38	-2.50%	―	-0.31%	47.17%
1827	51 Neutral	HK$424.00M	40.00	7.45%	―	-18.43%	―

Perfect Medical Health Management Limited Corporate Events

Perfect Medical Health Management Limited Enhances Nomination Committee Governance

Perfect Medical Health Management Limited has updated the terms of reference for its Nomination Committee, which was initially established in 2011. The amendments, effective from June 30, 2025, aim to enhance corporate governance by ensuring a diverse and independent committee structure, which includes a majority of independent non-executive directors and at least one member of a different gender. This move is expected to strengthen the company’s governance framework and align with best practices, potentially impacting its reputation positively in the market.

Perfect Medical Health Management Limited Reports Decreased Revenue Amid Economic Challenges

Perfect Medical Health Management Limited reported a 19.1% decrease in revenue to HK$1,127.9 million and a 34.5% decline in profit attributable to equity holders to HK$206.9 million for the year ended 31 March 2025. The company’s performance was affected by economic challenges and increased competition in Mainland China. In response, the company launched new services and strengthened its loyalty program, maintaining a high net profit margin of 18.3%. Despite the challenging market conditions, the company proposed a final dividend of HK5.3 cents per share, maintaining a 100.6% annual dividend payout ratio, and has consistently delivered shareholder returns with over HK$3.28 billion in cumulative dividends since 2012.

Perfect Medical Health Management Limited Announces Final Dividend for FY2025

Perfect Medical Health Management Limited has announced a final cash dividend of HKD 0.053 per share for the financial year ending March 31, 2025. This decision, approved by shareholders and set to be paid on September 5, 2025, reflects the company’s stable financial performance and commitment to returning value to its shareholders.

Perfect Medical Health Management Issues Profit Warning Amid Market Challenges

Perfect Medical Health Management Limited has issued a profit warning, expecting a decline in profit attributable to shareholders for the year ending March 2025 due to economic downturn and weak consumer sentiment in Hong Kong. The company is responding to these challenges by enhancing its service offerings, strengthening its membership loyalty program, and advancing digitalization to improve customer experience. Despite the market difficulties, the company maintains a strong balance sheet and continues to pay high dividends, while also seeking growth opportunities through strategic partnerships and acquisitions in the medical beauty sector.

Perfect Medical Health Management Schedules Board Meeting for Annual Results

Perfect Medical Health Management Limited has announced a board meeting scheduled for June 27, 2025, to approve the annual results for the fiscal year ending March 31, 2025, and to consider the payment of a final dividend. This announcement highlights the company’s ongoing financial management and strategic planning, which could impact its market positioning and shareholder value.